FAQ

Potassium aminobenzoate

Known as: Aminobenzoate Potassium, Potassium p-Aminobenzoate, 4 Aminobenzoic Acid, Potassium Salt 
The potassium salt form of aminobenzoate, with anti-inflammatory and antifibrotic activities. Aminobenzoate potassium increases oxygen uptake at the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1953-2016
02419532015

Related topics

Related topics

6 relations

Broader (1)

4-Aminobenzoic Acid
DermatomyositisFibrosisPemphigusSystemic Scleroderma

Narrower (1)

Potaba

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Potassium aminobenzoate
Fibrosis
Systemic Scleroderma
Pemphigus
4-Aminobenzoic Acid
Dermatomyositis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Acute hepatitis associated with treatment of Peyronie's disease with potassium para-aminobenzoate (Potaba).
INTRODUCTION Potassium para-aminobenzoate is an agent used in the treatment of sclerotic diseases including Peyronie's disease of… (More)
  • table 1
  • table 2
Is this relevant?
1994
1994
Comparison of aminobenzoate potassium and placebo in the treatment of scleroderma.
OBJECTIVE To determine the safety and efficacy of aminobenzoate potassium (KPAB) in treating the skin manifestations of… (More)
Is this relevant?
1989
1989
Retrospective studies in scleroderma: pulmonary findings and effect of potassium p-aminobenzoate on vital capacity.
The principal clinical pulmonary findings were extracted from University of Michigan Hospital records of 390 patients with… (More)
Is this relevant?
1988
1988
Retrospective studies in scleroderma: effect of potassium para-aminobenzoate on survival.
Demographic and survival data are presented for 390 patients with scleroderma. For the entire group an estimated 81.4% survived 5… (More)
  • table 2
  • figure 1
  • table 3
  • figure 2
  • table 4
Is this relevant?
1988
1988
Retrospective studies in scleroderma: skin response to potassium para-aminobenzoate therapy.
Analyses were made of University of Michigan Hospital records of 467 patients diagnosed during the period 1948 - July 1980 as… (More)
Is this relevant?
1986
1986
Potassium para-aminobenzoate and liver function test findings.
Risk of hepatotoxicity has been raised with respect to potassium para-aminobenzoate (Potaba) therapy. In this regard relevant… (More)
Is this relevant?
1984
1984
Treatment of lichen sclerosus with potassium para-aminobenzoate.
In five patients with symptomatic lichen sclerosus, significant clinical improvement was obtained following the administration of… (More)
Is this relevant?
1981
1981
Eosinophilic fasciitis: clinical, laboratory, and microscopic considerations.
Two patients with clinical and pathologic features of eosinophilic fasciitis manifested serologic and systemic abnormalities that… (More)
Is this relevant?
1979
1979
Effects of potassium para-aminobenzoate on growth and macromolecule synthesis in fibroblasts cultured from normal and sclerodermatous human skin, and rheumatoid synovial cells.
Potassium para-aminobenzoate was tested for its ability to affect growth and macromolecule synthesis in vitro using fibroblasts… (More)
Is this relevant?
1959
1959
Treatment of Peyronie's disease with potassium para-aminobenzoate (potaba).
 
Is this relevant?